Categories Earnings, Other Industries

Earnings preview: Tiffany might not shine in Q2

Tiffany & Co. (NYSE: TIF) is scheduled to report second quarter 2019 earnings results on Wednesday, August 28, before the opening bell. The consensus estimate is for earnings of $1.05 per share on revenue of $1.06 billion.

Tiffany has been struggling with declining sales across all its geographical regions. Comparable store sales have also dropped, pulled down by decreases in all its markets. The results have been impacted by lower worldwide spending attributed to foreign tourists, and foreign exchange headwinds. These challenges are likely to continue in the second quarter putting pressure on both the top and bottom line numbers.  

Tiffany reports first quarter 2019 earnings results

There are speculations that the Hong Kong protests could impact tourism and this in turn could take a toll on Tiffany’s sales. The ongoing trade war, the resultant tariffs and the economic headwinds in China might also dampen the topline results.

Tiffany recently launched its men’s jewelry and lifestyle line in order to expand its product offerings and tap into an entirely new customer base. Earlier this month, the company announced its plans to open new stores in India through a joint venture with Reliance Brands Limited. Updates on these efforts will be interesting to watch.

Also see: Tiffany Q1 2019 Earnings Conference Call Transcript

In the first quarter of 2019, Tiffany reported better-than-expected earnings while revenues missed estimates. Net sales fell 3% to $1 billion while EPS dropped 10% to $1.03. Comparable sales decreased 2%. The company saw declines in both net sales and comp sales across all its geographical regions last quarter.

For fiscal 2019, the management expects worldwide net sales to increase by a low-single-digit percentage from last year, reflecting an increase of the same degree in comparable sales. Earnings, on a per share basis, are forecast to grow by a low-to-mid-single-digit percentage. 

Tiffany’s shares have gained 7% year-to-date. The stock has an average price target of $103.30.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top